Nicotine information and how different tobacco products affect priority populations
Communicating about Nicotine and Differential Risks of Tobacco Products in Priority Populations
This project uses clear messages together with very low nicotine cigarettes to help smokers—especially people with mental health conditions or low income—understand risks and reduce smoking.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgia State University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11262877 on NIH RePORTER |
What this research studies
If you smoke and are in a priority group, researchers will provide targeted messages about very low nicotine cigarettes (VLNCs) and offer opportunities to use these products under controlled conditions. The team combines previous clinical trials of VLNCs with new communication experiments so you will see real messages while using the product rather than only answering hypothetical questions. They will track changes in beliefs, smoking behavior, and related outcomes over time. Findings will be used to shape public-facing messages and policy implementation that aim to protect communities with higher tobacco-related harm.
Who could benefit from this research
Good fit: Ideal candidates are adult cigarette smokers in priority populations—such as people with mental health conditions or low socioeconomic status—who are willing to receive messages and try very low nicotine cigarettes under study conditions.
Not a fit: People who do not smoke, only use e-cigarettes, or are unwilling to try very low nicotine products are unlikely to benefit directly from participating.
Why it matters
Potential benefit: If successful, this work could lead to clearer public messages and policies that help smokers understand nicotine and reduce smoking-related harm.
How similar studies have performed: Previous randomized trials showed VLNCs can reduce dependence and cigarettes smoked per day, but combining these trials with actual messaging and behavioral measurement is a newer and less-tested approach.
Where this research is happening
Atlanta, United States
- Georgia State University — Atlanta, United States (Active)
Researchers
- Principal investigator: Popova, Lyudmila — Georgia State University
- Study coordinator: Popova, Lyudmila
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.